简介内容:SD-6, an orally active inhibitor targeting both hAChE and hBChE, demonstrates IC50 values of ?M and ?M, respectively. With its excellent blood-brain barrier (BBB) permeability and lack of neurotoxicity, SD-6 holds potential for Alzheimer´s disease research.